UGT inhibition risk
basic_ugt_inhibition_risk.Rd
This function evaluates the clinical risk for reversible inhibition of UGT enzymes according to the relevant regulatory guideline.
Details
This function assumes that the UGT inhibition data is provided as \(IC_{50}\). According to Cheng, Prusoff 1973), \(K_i\) can be assumed to be \(IC_{50}/2\) at the experimental conditions commonly used in the in vitro inhibition studies where substrate concentrations are close to \(K_M\).
The relevant metric for basic modeling of the UGT inhibition risk is \(R=C_{max,ss,u}/K_{i,u}\)
Refer to Section 2.1.2.1 of the ICH M12 guidance document) for details.
\(R>0.02\) are considered to indicate a potential UGT inhibition risk.
Examples
basic_ugt_inhibition_risk(examplinib_parent, examplinib_ugt_inhibition_data)
#> ugt kiu r risk
#> 1 UGT1A1 7.50 0.02197591 TRUE
#> 2 UGT1A3 7.50 0.02197591 TRUE
#> 3 UGT1A4 7.50 0.02197591 TRUE
#> 4 UGT1A6 7.50 0.02197591 TRUE
#> 5 UGT1A9 1.90 0.08674701 TRUE
#> 6 UGT2B7 7.50 0.02197591 TRUE
#> 7 UGT2B15 7.50 0.02197591 TRUE
#> 8 UGT2B17 3.05 0.05403912 TRUE